Jotin Marango

Dr. Marango is the Chief Business Officer and Senior Vice President at Aptose Biosciences, a clinical stage company developing precision therapies in hematology and oncology. Prior to joining Aptose, Dr. Jotin Marango was a managing director and senior research analyst at Roth Capital Partners covering oncology with a focus on epigenetic and molecularly targeted therapies, as well as pulmonary medicine and allergy therapeutics. Dr. Marango began his career in equity research with Collins Stewart/Canaccord Genuity. Previously, Dr. Marango also served as Chief Operating Officer at the Samuel Waxman Cancer Research Foundation, where he oversaw academic collaborations in translational therapeutics, as well as venture philanthropy initiatives in drug development. Dr. Marango studied chemistry and classical literature at Harvard University and later received his Doctor of Medicine and Doctor of Philosophy degrees from the Mount Sinai School of Medicine of New York University.